Eloxx Pharmaceuticals Stock Price - ELOX

1.91
0.35 (22.44%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Eloxx Pharmaceuticals Inc ELOX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.35 22.44% 1.91 1.63 1.91 1.73 1.56 12:06:09
Bid Price Ask Price Spread Spread % News
1.89 1.91 0.02 1.05% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
317 46,768 $ 1.82 $ 85,001 126,552 1.44 - 13.46
Last Trade Time Type Quantity Stock Price Currency
12:06:09 100 $ 1.91 USD

Eloxx Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 76.64M 40.13M $ -47.19M -1.34 - 20.55M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 19.00 48.80%

more financials information »

Eloxx Pharmaceuticals News

Loading Messages....

Latest ELOX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ELOX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.172.181.441.7288,282-0.26-11.98%
1 Month3.553.601.442.45127,160-1.64-46.2%
3 Months7.597.851.443.75154,912-5.68-74.84%
6 Months3.618.16141.445.30220,079-1.70-47.09%
1 Year11.3513.461.445.96148,410-9.44-83.17%
3 Years10.3524.601.449.52119,973-8.44-81.55%
5 Years10.3524.601.449.52119,973-8.44-81.55%

Eloxx Pharmaceuticals Description

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel ribonucleic acid (RNA)-modulating drug candidates that are formulated to treat rare and ultra-rare premature stop codon diseases. The ELX-02, the company's lead investigational drug product candidate, is a small molecule designed to restore the production of full-length functional proteins. The ELX-02, is in the early stages of clinical development for systemic administration for cystic fibrosis and cystinosis.


Your Recent History
NASDAQ
ELOX
Eloxx Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.